Personalized bacterial vaccine shows promise as cancer immunotherapy

Columbia researchers have engineered probiotic bacteria that educate the immune system to destroy cancer cells, opening the door for a new class of cancer vaccines that take advantage of bacteria’s natural tumor-targeting properties. These microbial cancer vaccines can be personalized to attack each individual’s primary tumor and metastases, and may even prevent future recurrences.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup